Table 3 : Comparison of hypoglycemic episodes before and after treatment with basal insulin analogs (N=38).


Asymptomatic hypoglycaemic episodes, n (%)

  At least 5 months of treatment p-value*
  No Yes
Start of treatment No 28 (73.7) 2 (5.3) >0.05
Yes 7 (18.4) 1 (2.6)
Symptomatic hypoglycaemic episodes, n (%)
  At least 5 months of treatment p-value*
  No Yes
Start of treatment No 22 (57.9) 1 (2.6) <0.01
Yes 13 (34.2) 2 (5.3)

*McNemar's test for paired data.

Bellido-Guerrero et al.Journal of Diabetes Research and Clinical Metabolism  2013 2:20DOI : 10.7243/2050-0866-2-20